相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CHF5074, a Novel gamma-Secretase Modulator, Restores Hippocampal Neurogenesis Potential and Reverses Contextual Memory Deficit in a Transgenic Mouse Model of Alzheimer's Disease
Bruno P. Imbimbo et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Modulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease
Maria Z. Kounnas et al.
NEURON (2010)
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
Bart De Strooper
PHYSIOLOGICAL REVIEWS (2010)
Purification, Pharmacological Modulation, and Biochemical Characterization of Interactors of Endogenous Human γ-Secretase
Edith Winkler et al.
BIOCHEMISTRY (2009)
Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease A Randomized Controlled Trial
Robert C. Green et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
gamma-secretase modulation and its promise for Alzheimer's disease: a medicinal chemistry perspective
Ilaria Peretto et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
Generation of Aβ38 and Aβ42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and γ-secretase modulation
Richard M. Page et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
1-(3′,4′-dichloro-2-fluoro[1,1′-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel γ-secretase modulator, reduces brain β-amyloid pathology in a Transgenic mouse model of Alzheimer's disease without causing peripheral toxicity
Bruno P. Imbimbo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Insensitivity to Aβ42-lowering nonsteroidal anti-inflammatory drugs and γ-secretase inhibitors is common among aggressive presenilin-1 mutations
Eva Czirr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The geminal dimethyl analogue of Flurbiprofen as a novel Aβ42 inhibitor and potential Alzheimer's disease modifying agent
N Stock et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Evidence that Perutz's double-β-stranded subunit structure for β-amyloids also applies to their channel-forming structures in membranes
SJ Singer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
γ-Secretase substrate selectivity can be modulated directly via interaction with a nucleotide-binding site
PC Fraering et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Aβ42 is essential for parenchymal and vascular amyloid deposition in mice
E McGowan et al.
NEURON (2005)
Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Aβ42 production
T Kukar et al.
NATURE MEDICINE (2005)
Chronic treatment with the γ-secretase inhibitor LY-411,575 inhibits β-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation
GT Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Pain: Moving from symptom control toward mechanism-specific pharmacologic management
CJ Woolf
ANNALS OF INTERNAL MEDICINE (2004)
Modulation of nuclear factor-κB activity by indomethacin influences Aβ levels but not ap precursor protein metabolism in a model of Alzheimer's disease
S Sung et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Modulation of notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation
J Milano et al.
TOXICOLOGICAL SCIENCES (2004)
Novel aspects of accumulation dynamics and AP composition in transgenic models of AD
HD Lewis et al.
NEUROBIOLOGY OF AGING (2004)
Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional γ-secretase inhibitor
GH Searfoss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid β42 production by direct modulation of γ-secretase activity
S Weggen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Aβ42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain
S Weggen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
JL Eriksen et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Characterization of amyloid β peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein
S Pype et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Selective inhibition of Aβ42 production by NSAID R-enantiomers
T Morihara et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
HF Dovey et al.
JOURNAL OF NEUROCHEMISTRY (2001)
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
S Weggen et al.
NATURE (2001)
γ-secretase inhibitors repress thymocyte development
BK Hadland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease
K Terai et al.
NEUROSCIENCE (2001)
分享论文
